Sun, Haiyan <br/><br/>
Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2.  [electronic resource] 

 -  The Biochemical journal  Aug 2012 
 - 377-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1470-8728 
<br/><br/><label>Standard No.: </label>10.1042/BJ20120820  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aryl Hydrocarbon Hydroxylases--metabolism<br/>Cysteine Endopeptidases--metabolism<br/>Cytochrome P-450 CYP2B1--metabolism<br/>Genes, Tumor Suppressor<br/>Hepatocytes--drug effects<br/>In Vitro Techniques<br/>Interleukin-1--pharmacology<br/>Kinetics<br/>Male<br/>Metabolic Networks and Pathways<br/>Models, Biological<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Donors--pharmacology<br/>Nitric Oxide Synthase Type II--antagonists & inhibitors<br/>Nuclear Proteins<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors<br/>Rats<br/>Rats, Inbred F344<br/>Steroid Hydroxylases--metabolism